Starquest Capital
China fundraising: Onshore vs offshore
Raising capital for China strategies is difficult right now, regardless of currency, but are geopolitical forces enabling the rise of renminbi-denominated funds at the expense of the US dollar?
Renminbi GPs wary of government guidance funds as LPs
Chinese government guidance funds represent a potentially rich source of capital for managers in the renminbi-denominated space, but some are reluctant to take it, the Hong Kong Venture Capital & Private Equity Association's (HKVCA) China forum heard.
2022 preview: China sustainability
Green-tech investment, from electric vehicles to renewable energy, is already in the ascendency as China ponders a carbon-neutral future. Momentum is expected to grow in 2022
China cleantech: Policy tailwinds
Private equity investment in China cleantech and renewables is at record levels, spurred by robust government support for the industry and a recognition that this time the boom might be sustainable
Q&A: Starquest Capital's Frankie Fang
Frankie Fang, founding managing partner of China-focused fund-of-funds Starquest Capital, discusses early-stage valuations, specialization among domestic managers, and renminbi fundraising
China clean energy: Policy power
China’s aggressive renewable energy development targets are creating opportunities for investors in various points along the supply chain, but inconsistent regulation remains a concern
Asia gyms: Muscling through the mire
Fitness centers have continued to woo investors during COVID-19 despite patchy progress in the reopening of gyms and difficult-to-digitize business models
ESG and VC: Deferred dialogue
Institutional LPs are traditionally less engaged with VC versus PE when it comes to responsible investment standards. A multitude of drivers are changing this, but not quickly
China's Miaoshou Doctor hits $1b valuation
Miaoshou Doctor, a Chinese online healthcare services platform that has expanded into the offline pharmacy space, has completed its extended Series C funding round, having achieved a post-deal valuation of more than RMB7 billion ($1 billion).
Chinese gym operator SuperMonkey raises $53.5m
Chinese gym operator SuperMonkey has raised RMB360 million ($53.5 million) in a Series D round led by Starquest Capital and Yao Capital, a sport-focused PE firm co-founded by former NBA star Yao Ming.
China's Miaoshou Doctor raises $72.8m
China-based healthcare care services provider Miaoshou Doctor has raised RMB500 million ($72.8 million) in an extended Series C round of funding led by Starquest Capital, with participation from Sequoia Capital China.